Found 7 matching trials
Phase 2 Study Evaluating Apitegromab for the Treatment of FSHD
PHASE2A randomized Phase 2 study to evaluate the efficacy and safety of apitegrom...
Location
National Neuromuscular Research Institute
EAP of Apitegromab for Patients With Spinal Muscular Atrophy
N/AThe purpose of this expanded access program (EAP) is to provide access to a...
Status
No Longer Available
Location
Multiple Locations
Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
PHASE2A phase 2 study to evaluate the effects of apitegromab as an adjunctive the...
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of Apitegromab
PHASE3The ONYX study is an Open-Label, Multicenter, Extension study that will eva...
Status
Active Not Recruiting
Location
Phoenix Childrens Hospital
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
PHASE2This double-blind, Phase 2, multiple-dose study will be conducted to evalua...
Location
Phoenix Children's Hospital
Efficacy and Safety of Apitegromab in Patients With Later-Onset Spinal Muscular Atrophy Treated With Nusinersen or Risdiplam
PHASE3This Phase 3 trial (Study SRK-015-003) was conducted in patients ≥2 years o...
Location
Children's of Alabama
An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy
PHASE2The TOPAZ study will assess the safety and efficacy of SRK-015 in later-ons...
Location
Phoenix Children's Hospital